Phenotypic and functional characterisation of locally produced natural killer cells ex vivo expanded with the K562-41BBL-mbIL21 cell lineAdoptive immunotherapyEx vivo expansionLeukaemiaNatural killer cellsWe characterised the expansion, phenotype and functional activity of natural killer (NK) cells obtained ...
We proposed a phase 2, open, prospective, multicenter, nonrandomized clinical trial for the adoptive infusion of haploidentical K562-mb15-41BBL–activated and expanded NK (NKAE) cells as a consolidation strategy for children with favorable and intermediate risk AML in first complete remission after...
产品名称 K562-Puro+TNFSF9/41BBL(h) 稳转株 产品货号 VGC-0001-025P 中文名称 TNFSF9/41BBL(h) 过表达 K562 稳转株 Lot number K562-34H8P 细胞规格 复苏细胞 (T25细胞瓶) 或1 × 106 细胞冻存细胞 细胞形态 淋巴母细胞样 生长特性 悬浮生长 细胞株 构建流程 (1)构建目的基因过表达慢病毒重组质粒...
We proposed a phase 2, open, prospective, multicenter, nonrandomized clinical trial for the adoptive infusion of haploidentical K562-mb15-41BBLeactivated and expanded natural killer (NKAE) cells as a consolidation strategy for children with favorable and intermediate risk acute myeloid leukemia in ...
We proposed a phase II open, a prospective multicenter, non-randomized clinical trial for adoptive infusion of haploidentical K562-mb15-41BBL activated and expanded Natural Killer (NKAE) cells as a consolidation strategy in children with favorable and intermediate-risk AML who were in first ...